Cancer Biology · Metabolism · Immunology · Translation

Huang Lab

Gang Huang Lab is an interdisciplinary research group at UT Health San Antonio and Mays Cancer Center spanning hematology, solid tumors, metabolism, immunology, trauma research, and product development.

UT Health San Antonio and Mays Cancer Center

Huang Lab group photo

142

Peer-reviewed publications

9

Lab members

4

Research programs

2

Spinout companies

Overview

Welcome to the Huang Lab

At The Huang Lab, we are dedicated to advancing the understanding and treatment of human disease through rigorous, multidisciplinary research. Under the leadership of Dr. Gang Huang, our team seeks to bridge fundamental discoveries with real-world applications, with a particular emphasis on hematology, metabolism, cancer biology, medical product development, CAR T-cell therapy, trauma research, and military health.

We focus on the complexities of both blood-related cancers and solid tumors while exploring how metabolic pathways and immune responses influence disease progression. By integrating expertise across these domains, we strive to develop innovative interventions that improve patient care and outcomes worldwide.

How we work

From bench to business to bedside

  1. Discovery

    Mechanisms of cancer, metabolism, immune dysfunction, and trauma at the bench.

  2. Validation

    Models and translational assays that pressure-test each target and technology.

  3. Spinout

    Companies formed around validated technologies — like Powerhouse Therapeutics and Abioremedi.

  4. Development

    IND-enabling studies, manufacturing, capital, and partnerships that carry products to market.

  5. Bedside

    Therapies reaching patients — in clinics, trauma care, and the field.

Research

Programs in motion

See all projects

Cancer-Associated Cachexia

The lab investigates the metabolic and inflammatory drivers of cachexia to identify biomarkers, mechanisms, and intervention points that improve patient outcomes.

MetabolismInflammationBiomarkers

Blood Disorders and Hematologic Malignancies

The lab studies MDS, MPN, acute leukemia, and blood disorders by connecting stem cell regulation with mitochondrial metabolism and epigenetic control.

MDS / MPNLeukemiaStem cells

Solid Tumor Immunotherapies

The lab builds next-generation immunotherapies for solid tumors, with emphasis on liver cancer, CAR T-cell engineering, and the tumor immune microenvironment.

Liver cancerCAR TTumor microenvironment

Trauma and Military Health

The lab develops synthetic blood oxygen carriers and trauma-relevant therapeutics, working with the U.S. Army Institute of Surgical Research and Department of Defense partners.

Blood oxygen carriersUS Army ISRDoD collaborations

Spin-outs

Companies spun out

Company profiles

Powerhouse Therapeutics

A Huang Lab spinout developing solid tumor immunotherapies, led by its IT-ACTS platform.

Abioremedi

A Huang Lab spinout developing a synthetic blood oxygen carrier for trauma, transfusion medicine, and battlefield care.

Join the lab

Join our team

The lab welcomes postdoctoral scholars, graduate students, undergraduates, post-baccalaureate researchers, and staff who want to work on cancer biology, metabolism, immunology, genetics, and translational therapeutics.

Prospective trainees should fill out the application form and contact current lab members about positions.

News

Recent updates

View all news